Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intracel
Frederick, Maryland, United Statesintracel.co.uk ↗
- Ownership
- Public · ITCI
- Development stage
- Other
01
Overview
Intracel developed OncoVAX, a patient-specific autologous colon cancer vaccine. The company received FDA Special Protocol Assessment for a confirmatory pivotal Phase III study of OncoVAX in colon cancer as of July 2006. There is no evidence the company or its programs have advanced since then, and it appears to be inactive[7].
- Therapeutic areas
- Oncology
- Modalities
- VaccineImmunotherapyCell therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Intracel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intracel.